drugset / Trial / NCT00072384

Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma

NCT00072384 ↗

NaSingle-groupOpen-labelTreatment

Summary

Phase III trial to determine the effectiveness of combining systemic chemotherapy and subtenon carboplatin with ophthalmic therapy in treating children who have intraocular retinoblastoma. Drugs used in chemotherapy, such as vincristine, carboplatin, and etoposide, work in different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether systemic chemotherapy and subtenon (under the conjunctiva of the eye) carboplatin combined with ophthalmic therapy is effective in treating intraocular (within the eyeball) retinoblastoma.

Timeline

Start
2007-04-16
Primary completion
2013-02-01
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Etoposide Small molecule — Intravenous
Subject liposomal vincristine sulfate Unknown — Intravenous
Background filgrastim Protein / enzyme biologic — Subcutaneous